ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Protagonist Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – PTGX
April 26, 2022 13:48 ET
|
The Rosen Law Firm PA
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Protagonist...